These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8279450)

  • 1. Review of negative Papanicolaou tests. Is the retrospective 5-year review necessary?
    Allen KA; Zaleski S; Cohen MB
    Am J Clin Pathol; 1994 Jan; 101(1):19-21. PubMed ID: 8279450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assessment and improvement of "Unsatisfactory" liquid-based cervicovaginal papanicolaou smears.
    Mirzamani N; Chau K; Rafael O; Shergill U; Sajjan S; Sumskaya I; Gimenez C; Klein M; Das K
    Diagn Cytopathol; 2017 Oct; 45(10):873-877. PubMed ID: 28752611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
    Sherman ME; Kelly D
    Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
    Koss LG; Lin E; Schreiber K; Elgert P; Mango L
    Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear.
    Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ
    Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
    Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
    Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women.
    Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
    Cancer; 2001 Feb; 93(1):1-7. PubMed ID: 11241259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
    Chacho MS; Mattie ME; Schwartz PE
    Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the Papanicolaou smear: new issues for the 1990s.
    Ollayos CW
    Mil Med; 1997 Aug; 162(8):521-3. PubMed ID: 9271901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening?
    Kanber Y; Charbonneau M; Auger M
    Cancer Cytopathol; 2015 Dec; 123(12):739-44. PubMed ID: 26348845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance.
    Raab SS; Geisinger KR; Silverman JF; Thomas PA; Stanley MW
    Am J Clin Pathol; 1998 Nov; 110(5):653-9. PubMed ID: 9802352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Study of Pap Smears in HIV-Positive and HIV-Negative Women from a Tertiary Care Center in South India.
    Gupta K; Philipose CS; Rai S; Ramapuram J; Kaur G; Kini H; Gv C; Adiga D
    Acta Cytol; 2019; 63(1):50-55. PubMed ID: 30721904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of negative Papanicolaou tests: is the retrospective 5-year review necessary.
    Rubio CA
    Am J Clin Pathol; 1994 Aug; 102(2):266. PubMed ID: 8042598
    [No Abstract]   [Full Text] [Related]  

  • 16. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL; Acosta D; Peters RK
    Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical problem with calculating the false-negative rate of Papanicolaou smear interpretation by rescreening negative cases alone.
    Renshaw AA
    Cancer; 1999 Dec; 87(6):351-3. PubMed ID: 10603188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG; Zeferino LC; Hardy E; Westin MC; Martinez EZ; Montemor EB
    Acta Cytol; 2005; 49(3):244-8. PubMed ID: 15966284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
    Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid rescreen: a viable alternative to 1:10?
    Dudding N
    Diagn Cytopathol; 2001 Mar; 24(3):219-21. PubMed ID: 11241909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.